Experience

Dualitas Therapeutics Launches With $65 Million Series A

September 16, 2025

Cooley advised Dualitas, a biotechnology company pioneering next-generation bispecific antibody therapies for immunology and inflammation, on its $65 million Series A financing, to advance a portfolio of next-generation bispecific antibodies, including lead programs DTX-103 in allergic disease and DTX-102 for autoimmune disease, and to accelerate the development of Dualitas’ proprietary DualScreen BsAb discovery engine.

Read more

Related contacts

Sara Semnani
Partner, Santa Monica
Noel Ripberger-Scheick
Associate, Palo Alto
Sam Thompson
Associate, Santa Monica
Michael Aridi Barake
Associate, Santa Monica
Cameron Hajialiakbar
Associate, Santa Monica
Christy Fairlie
Paralegal Specialist, Reston
Jake Ironfield
Transactional Quantitative Analyst, New York
Dillon Martinson
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
John Sellers
Senior Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kelley Harrington
Associate, Chicago
Shelby Saunders
Associate, New York

Related Practices & Industries

SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion

May 28, 2025

Cooley advised SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on its acquisition by Eli Lilly.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Rena Kaminsky
Special Counsel, Palo Alto
Todd Gluth
Partner, San Diego
Lila Hope
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Tucker Cochenour
Associate, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
David Fletcher
Partner, Washington, DC
Jamie Leigh
Partner, San Francisco
Carly Mitchell
Partner, Washington, DC
Jeremy Morrison
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Marty Schenker
Senior Counsel , San Francisco
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Selin Akkan
Associate, Palo Alto
Mari Dugas
Associate, Washington, DC
Virat Gupta
Associate, Washington, DC
Eileen Leman
Associate, Los Angeles
Joseph Perry
Associate, Reston
Hannah Rausch
Associate, New York
Melody Van Horn
Senior Paralegal, Palo Alto

Related Practices & Industries

Reducto Announces $24.5 Million Series A

April 25, 2025

Cooley represented Reducto, a platform for unlocking unstructured data for artificial intelligence pipelines, on its $24.5 million Series A financing.

Read more

Related contacts

Tara Capsuto
Partner, San Francisco
Jeremy Ungerman-Sears
Associate, San Francisco
Julianne Orr
Associate, San Francisco
John Sellers
Senior Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Karen Tsai
Special Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Chu Lee
Paralegal Specialist, San Francisco
Michael Suyat
Senior Paralegal, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Logik.ai Announces Acquisition by ServiceNow

April 3, 2025

Cooley advised Logik.ai, an industry leader offering a modern, artificial intelligence (AI)-powered, composable configure, price and quote solution, on its acquisition by ServiceNow (NYSE: NOW), the AI platform for business transformation.

Read more

Related contacts

Sepideh Mousakhani
Partner, Palo Alto
Jon Gavenman
Partner, Palo Alto
Sangitha Palaniappa
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Caitlin Courtney
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Stella Sarma
Partner, Brussels
Timothy Shapiro
Partner, Palo Alto
Steve Tonsfeldt
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Bryan Berman
Special Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Kristin O'Hanlon
Special Counsel, San Francisco
Karen Tsai
Special Counsel, Washington, DC
Tamara Chin Loy
Associate, Washington, DC
Joshua Elefant
Associate, Palo Alto
Yichen Liu
Associate, Palo Alto
Michael Pelle
Associate, New York
Breanna Qin
Associate, Palo Alto
Erica Russell
Associate, San Francisco
Kealan Santistevan
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Christopher Suhler
Associate, Colorado
Chris Rhem
Paralegal Specialist, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

SiteOne Therapeutics Announces $100 Million Series C

December 18, 2024

Cooley advised SiteOne Therapeutics, a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough and other conditions, on its $100 million Series C financing.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Noel Ripberger-Scheick
Associate, Palo Alto
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
John Sellers
Senior Counsel, Palo Alto
Denny Won
Partner, San Francisco
Kimberly Nguyen
Special Counsel, Reston
Kristin O'Hanlon
Special Counsel, San Francisco
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Michelle Liskanich
Associate, Santa Monica
Michael Gladstone
Associate, New York
Sarah Oliai
Associate, Washington, DC
Melody Van Horn
Senior Paralegal, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

View more

Admissions and credentials

California

Washington

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.